Compounds having effect of activating SIRT6 deacetylation activity, SIRT6 activator and application of SIRT6 activator

A compound and acetylation technology, applied in organic active ingredients, medical preparations containing active ingredients, organic chemistry, etc., can solve problems such as acetylation activity needs to be improved

Inactive Publication Date: 2020-01-03
SHANGHAI JIAOTONG UNIV SCHOOL OF MEDICINE
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Patent CN109384694A discloses a SIRT6 small-molecule agonist with a triphenylcyclobissulfonamide as the mother nucleus, but the acetylation activity of the SIRT6 small-molecule agonist still needs to be improved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compounds having effect of activating SIRT6 deacetylation activity, SIRT6 activator and application of SIRT6 activator
  • Compounds having effect of activating SIRT6 deacetylation activity, SIRT6 activator and application of SIRT6 activator
  • Compounds having effect of activating SIRT6 deacetylation activity, SIRT6 activator and application of SIRT6 activator

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Embodiment 1: the synthesis of compound 1~18

[0034] In this example, the above-mentioned compounds having the structures represented by the formulas (compounds 1-18) are provided. The reaction scheme is as follows:

[0035]

[0036] The specific preparation method is as follows.

[0037] Synthetic Intermediate I: Methyl 2-(N-(5-bromo-4-fluoro-2-methylphenyl)sulfamoyl)-5-nitrobenzoate

[0038]

[0039] At room temperature, the raw material aniline compound (10 g, 49.0 mmol) was dissolved in 20 mL of pyridine, and the raw material 4-nitro-2-carboxymethylbenzenesulfonyl chloride (16.45 g, 58.8 mmol) was added, and the reaction was carried out at room temperature for more than 8 hours. After the completion of the reaction as monitored by TLC, the reaction was cooled to room temperature, and 1N hydrochloric acid was added to adjust the pH to 3-4. A pale yellow precipitate precipitated, which was filtered and dried to obtain the intermediate Int I (18.6 g, yield: 84...

example 1

[0050] Example 1 (compound 1): 2-(N-(5-bromo-4-fluoro-2-methylphenyl)sulfamoyl)-5-((3,5-dichlorophenyl)sulfonyl) benzamide

[0051] 1 H NMR (400MHz, DMSO-d 6 )δ11.28(s,1H),8.78(s,1H),8.35(s,1H),7.97(t,J=1.9Hz,1H),7.94(s,1H),7.77(d,J=2.0 Hz, 2H), 7.39(d, J=8.6Hz, 1H), 7.28–7.12(m, 4H), 1.89(s, 3H). 13 C NMR (101MHz, DMSO) δ170.69, 156.65 (d, J=244.3Hz), 137.24, 136.67, 136.60, 135.59, 134.35 (d, J=4.1Hz), 133.12, 133.04, 133.02, 130.80, 125.60, 110.281, ,118.55(d,J=22.9Hz),104.65(d,J=22.1Hz),17.46.MS(ESI)m / z:609.9(M+H) + .

example 2

[0052] Example 2 (Compound 2): 2-(N-(5-bromo-4-fluoro-2-methylphenyl)sulfamoyl)-5-((3,5-dichlorophenyl)sulfonyl) -N-Methylbenzamide

[0053] 1 H NMR (400MHz, DMSO-d 6 )δ11.30(s,1H),8.85(d,J=6.3Hz,1H),8.80(s,1H),8.01(dt,J=6.4,1.9Hz,1H),7.85(d,J=1.9 Hz,2H),7.47(dd,J=8.9,1.7Hz,1H),7.35(dd,J=8.6,2.4Hz,1H),7.28(t,J=2.4Hz,1H),7.21(d,J =6.7Hz,1H),7.12(dd,J=9.6,3.1Hz,1H),2.68(s,3H),1.90(s,3H). 13 C NMR (101MHz, DMSO) δ167.90, 156.75 (d, J = 244.6Hz), 142.22, 141.74, 137.41, 136.91 (d, J = 7.9Hz), 135.81, 133.72, 132.83 (d, J = 3.1Hz), 131.92 ,131.21,130.90,125.73,119.65,118.73,118.50(d,J=23.0Hz),104.62(d,J=22.1Hz),34.68,17.57.MS(ESI)m / z:623.9(M+H) + .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides compounds having an effect of activating SIRT6 deacetylation activity, or a pharmaceutically acceptable salt of the compounds. The compounds have a structure represented a formula (I) shown in the description. The invention also provides a SIRT6 activator obtained by using the compounds and an application of the SIRT6 activator in preparation of a medicine for treating SIRT6-mediated related diseases.

Description

technical field [0001] The present invention relates to the technical field of medicinal chemistry, in particular to a compound having the activity of stimulating SIRT6 acetylation, a SIRT6 agonist obtained by using the compound, and the use of the SIRT6 agonist in the preparation of drugs for treating SIRT6-mediated related diseases. application. Background technique [0002] SIRT6 belongs to the III family of histone deacetylases (HDACs) and contains seven members (SIRT1-7). SIRT6 is widely expressed in various tissues of mammals. In vivo, SIRT6 mainly participates in genome stability maintenance, DNA repair, inflammation and glucose and Lipid metabolism, and is closely related to heart disease, diabetes, obesity, cancer, aging and other diseases. Up-regulation of SIRT6 activity is considered to be one of the new strategies to treat the above-mentioned diseases, so the research on SIRT6 small molecule agonists is of great significance to the development of drugs for SIRT...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(China)
IPC IPC(8): C07C311/44C07D205/04C07D305/08C07D295/192C07D285/135C07D257/04C07D207/323A61K31/63A61P29/00A61P3/10A61P3/06A61P9/00A61P3/04A61P35/00A61P39/06
CPCA61P3/04A61P3/06A61P3/10A61P9/00A61P29/00A61P35/00A61P39/06C07C311/44C07D205/04C07D207/323C07D257/04C07D285/135C07D295/192C07D305/08C07C2601/02C07C2601/04C07C2601/08
Inventor张健赵明珠魏嘉呈
OwnerSHANGHAI JIAOTONG UNIV SCHOOL OF MEDICINE